Increasing evidence has demonstrated that GLP-1 analogues can cross the blood-brain barrier, protect dopaminergic neurons in the substantia nigra, and rescue motor activity and cognitive functions in PD animal models (5961)
Long-term use of these treatments requires ongoing monitoring and adjustments
If reducing appetite is your primary goal, this seems significant, but its still a side-effect report and not a direct measure of weight-loss results or medication strength. In the same dataset, abdomen injections also had higher reported nausea than the other sites, so some people may prefer a site that feels gentler even if it reports decreased appetite less often
These advantages translate into longer shelf life and more predictable degradation profiles
Semaglutide is designed with strong albumin binding and a ~7-day half-life, so it clears slowly no matter what you do
Treatment response If the treatment response with semaglutide is lower than expected, this may be due to low absorption caused by variability in absorption and low absolute bioavailability